PURPOSE. TO evaluate the efficiency of mitomycin C (MMC) in limiting the po
stoperative inflammatory response and scarring after strabismus surgery.
METHODS. A prospective, two-stage, masked, controlled trial was conducted.
In the first stage, the inflammatory response at the extraocular muscle rea
ttachment site was increased after inferior rectus recession in eight rabbi
ts. In the second stage, MMC (0.4 mg/ml) was applied during surgery to the
eyes of 22 rabbits with inferior rectus recession. As a control, contralate
ral eyes were treated with saline solution. Seven weeks later, exenteration
was performed, and the sites of muscle reattachment were processed for his
tologic examinations. The sums of the areas of the granulomas in the extrao
cular muscle reattachment sires of control and treated eyes were compared.
RESULTS. There was no significant inhibitory effect of MMC on the inflammat
ory response of treated eyes compared with that of control eyes.
CONCLUSIONS. The intraoperative use of MMC (0.4 mg/ml) was not effective in
controlling the postoperative inflammatory response in rabbit eyes after e
xtraocular muscle surgery. These data do not support the hypothesis that MM
C reduces postoperative adhesions after strabismus surgery.